ADARx Pharmaceuticals, Inc. (ADRX): 3 filed Sep 24, 2026

Form type
3
Filing date
Sep 24, 2026
Accession number
0001193125-26-401301
Filer
ADARx Pharmaceuticals, Inc. (CIK 1802369)